Literature DB >> 32310172

Crossing Borders Between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview.

Matteo Vismara1, Giovanna Cirnigliaro1, Eleonora Piccoli1, Federica Giorgetti1, Laura Molteni1, Laura Cremaschi1, Giorgio G Fumagalli2, Claudio D'addario3, Bernardo Dell'Osso1,4,5,6.   

Abstract

Frontotemporal dementia (FTD) includes a group of neurocognitive syndromes, clinically characterized by altered behaviors, impairment of language proficiency, and altered executive functioning. FTD is one of the most frequently observed forms of dementia in the elderly population and the most common in presenile age. As for other subtypes of dementia, FTD incidence is constantly on the rise due to the steadily increasing age of the population, and its recognition is now becoming a determinant for clinicians. FTD and psychiatric disorders can overlap in terms of clinical presentations by sharing a common genetic predisposition and neuropathological mechanism in some cases. Nonetheless, this association is often unclear and underestimated. Since its first reports, research into FTD has constantly grown, with the identification of recent findings related to its neuropathology, genetic, clinical, and therapeutic issues. Literature is thriving on this topic, with numerous research articles published in recent years. In the present review, we aimed to provide an updated description of the clinical manifestations that link and potentially confound the diagnosis of FTD and psychiatric disorders in order to improve their differential diagnosis and early detection. In particular, we systematically reviewed the literature, considering articles specifically focused on the behavioral variant FTD, published after 2015 on the PubMed database.

Entities:  

Keywords:  Behavioral symptoms; bipolar disorder; differential diagnosis; frontotemporal lobar degeneration; frontotemporal lobe dementia; genetics; neuroimaging; psychiatric zzm321990disorders; schizophrenia

Mesh:

Year:  2020        PMID: 32310172     DOI: 10.3233/JAD-191333

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  1 in total

Review 1.  Clinical uses of Bupropion in patients with Parkinson's disease and comorbid depressive or neuropsychiatric symptoms: a scoping review.

Authors:  Matteo Vismara; Beatrice Benatti; Gregorio Nicolini; Ilaria Cova; Edoardo Monfrini; Alessio Di Fonzo; Vincenza Fetoni; Caterina A Viganò; Alberto Priori; Bernardo Dell'Osso
Journal:  BMC Neurol       Date:  2022-05-05       Impact factor: 2.903

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.